Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-020638

CEO and Chairman sold 16,680 shares at an average $22.50 ($375,236)

  • CEO and Chairman acquired 16,680 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-19 Exercise or conversion : show line 1 in the form +11,120 $0.33 $3,670 1,889,300 D
2020-03-19 Sale : show line 2 in the form −11,120 $22.30 $247,976 1,878,180 D
2020-03-20 Exercise or conversion : show line 3 in the form +5,560 $0.33 $1,835 1,883,740 D
2020-03-20 Sale : show line 4 in the form −3,700 $22.37 $82,769 1,880,040 D
2020-03-20 Sale : show line 5 in the form −973 $23.50 $22,866 1,879,067 D
2020-03-20 Sale : show line 6 in the form −887 $24.38 $21,625 1,878,180 D
Open-market sales · 16,680 sh · avg $22.50 · $375,236

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-19 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −11,120 702,160 D
2020-03-20 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −5,560 696,600 D
Loading xslF345X03/doc4.xml…